Welcome to our dedicated page for AMPLIFON SPA UNSP/ADR news (Ticker: AMFPY), a resource for investors and traders seeking the latest updates and insights on AMPLIFON SPA UNSP/ADR stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect AMPLIFON SPA UNSP/ADR's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of AMPLIFON SPA UNSP/ADR's position in the market.
World Hearing Day 2023 revealed that over 1.5 billion people worldwide experience hearing loss, with forecasts predicting a rise to 2.5 billion by 2050. On this occasion, Amplifon Americas supports the World Health Organization by promoting free hearing tests across its Miracle-Ear stores. Research indicates a link between hearing loss and dementia risk, emphasizing the importance of early diagnosis. Amplifon aims to enhance awareness and accessibility of hearing care, expecting to generate over €200 million in user savings in 2023. The company also launched a global TikTok channel to educate young people about hearing health.
Miracle-Ear invites the community to visit its 1,500 stores nationwide on
Nationwide surveys by Amplifon Hearing Health Care reveal the critical role of provider recommendations and access to diverse hearing aid options in enhancing consumer satisfaction. A survey of 602 consumers ranked the importance of a wide selection of hearing aid brands highly (7.8/10), with 77% desiring knowledge of available brands before buying. Concurrently, 200 hearing care providers echoed these sentiments, emphasizing how a broad choice positively impacts patient satisfaction (9.4/10). The white paper highlights the health risks of untreated hearing loss and advocates for comprehensive hearing benefits.
Amplifon reaffirms its commitment to hearing care on World Hearing Day 2022, joining WHO's campaign “To Hear For Life, Listen With Care”. With 45 million Americans affected by hearing loss and 1.1 billion young people at risk globally, Amplifon emphasizes safe listening and prevention. The company trains nearly 2,500 hearing care professionals annually, supporting communities through the Miracle-Ear Foundation, which has donated over 21,000 hearing aids to those in need. Amplifon's sustainability plan promotes awareness around hearing loss prevention and responsible listening.
Amplifon Hearing Health Care has launched a new virtual care program, Telehealth for Hearing, to enhance access to hearing assessments and care across the U.S. This innovative solution includes the AmpliTest™ app for virtual screening, personalized coaching, and dedicated aftercare services. The program targets approximately 40 million people with undiagnosed hearing loss, aiming to reduce healthcare costs associated with untreated conditions. The economic impact is significant, with untreated patients facing $22,434 more in healthcare costs over a decade.
